Research page
TB-500

Specification
| Name | TB-500 |
|---|---|
| Catalog sizes | 10 mg |
| Adopted bacteriostatic water | 10 mg + 2.0 mL = 5 mg/mL |
Overview
In the catalog, TB-500 is a 10 mg vial. In the literature, that name is used for a fragment associated with thymosin β4, an actin-binding protein. TRACE does not equate the vial with a thymosin medicine.
Mechanism under study
The review by Goldstein, Hannappel, and Kleinman describes thymosin β4 as an actin-sequestering protein and surveys tissue-repair models. That is literature on the protein, not a trial of this vial.
What published research has reported
TRACE cites that 2005 review and does not add a clinical trial of the vial. There is no claim here of repair in a person.
Composition and mass
10 mg vial. Adopted bacteriostatic water: 2 mL (5 mg/mL).
Reconstitution
| mg | mL | mg/mL | |
|---|---|---|---|
| 10 | 2.0 | 5 | In the catalog |
Storage and handling
Lyophilized material cool, dry, and protected from light. Dissolved: 2–8 °C, not frozen, 28-day horizon.
Regulatory status
Research material. Not a drug, a supplement, or a food.